This study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Eric W. Dieperink, MD
Advertisement
Articles by Eric W. Dieperink, MD
Advertisement
Latest Updated Articles
- Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and Outcomes
Published: February 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
December 2025 Product Updates
2
Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy
3
A Healthy Gut Could Improve Mental Health
4
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
5